Mads joined UNION in 2018 and was in 2021 promoted to Chief Commercial Officer. He brings broad market access experience from Novo Nordisk A/S where he was part of building new functions for real world evidence generation and for innovative contracting. In these teams Mads was driving Novo Nordisk’s global efforts to initiate partnerships with payers and providers around evidence generation and developing new financial and outcomes-based approaches to secure access for products in hemophilia, diabetes and obesity.
Prior to specializing in market access, Mads has worked with both off-shoring and in Legal Affairs at Novo Nordisk and also has experience in management consulting at McKinsey & Company and in banking at Nordea Markets.
Mads holds a M.Sc. in Economics from University of Copenhagen.
